Literature DB >> 7002129

The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study.

W R Wilson, F M Byl, N Laird.   

Abstract

Double-blind studies were conducted for the treatment of idiopathic sudden hearing loss (ISHL) with oral steroids. The condition was defined as not less than a 30-dB loss over three contiguous frequencies in three days or less. Follow-up audiograms were obtained four weeks and three months later. Specific audiologic guidelines for the assessment of hearing recovery were used to ensure objectivity. Steroids had a statistically significant effect on the recovery of hearing in patients with moderate hearing losses. The nature of the hearing loss and its susceptibility to improvement with steroid therapy lend support to the hypothesis that viral cochlitis is the primary cause of ISHL.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002129     DOI: 10.1001/archotol.1980.00790360050013

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  156 in total

1.  A gene for fluctuating, progressive autosomal dominant nonsyndromic hearing loss, DFNA16, maps to chromosome 2q23-24.3.

Authors:  K Fukushima; N Kasai; Y Ueki; K Nishizaki; K Sugata; S Hirakawa; A Masuda; M Gunduz; Y Ninomiya; Y Masuda; M Sato; W T McGuirt; P Coucke; G Van Camp; R J Smith
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance.

Authors:  Young Ho Kim; Kyung Tae Park; Byung Yoon Choi; Min Hyun Park; Jun Ho Lee; Seung-Ha Oh; Sun O Chang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-08       Impact factor: 2.503

3.  Analysis of hearing improvement in patients with severe to profound sudden sensorineural hearing loss according to the level of pure tone hearing threshold.

Authors:  Seok Min Hong; Young Gil Ko; Chan Hum Park; Jun Ho Lee; Ji Heui Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-06       Impact factor: 2.503

4.  Intratympanic steroids in severe to profound sudden sensorineural hearing loss as salvage treatment.

Authors:  Jong Dae Lee; Moo Kyun Park; Chi-Kyou Lee; Kye Hoon Park; Byung Don Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-09-17       Impact factor: 3.372

5.  Acute Hearing Loss.

Authors:  Madhura Tamhankar; David Solomon
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

6.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

Review 7.  The role of glucocorticoids for spiral ganglion neuron survival.

Authors:  David Xu Jin; Zhaoyu Lin; Debin Lei; Jianxin Bao
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

8.  Transtympanic corticoid therapy for acute profound hearing loss.

Authors:  Jürgen Lautermann; Holger Sudhoff; Rüdiger Junker
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-03       Impact factor: 2.503

9.  Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.

Authors:  Haralampos Gouveris; Oksana Selivanova; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-29       Impact factor: 2.503

10.  Bilateral sudden hearing loss following habitual abortion: a case report and review of literature.

Authors:  Tuanfang Yin; Fengying Huang; Jihao Ren; Wei Liu; Xing Chen; Lihua Li; Dinghua Xie; Yongde Lu
Journal:  Int J Clin Exp Med       Date:  2013-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.